Top compounds associated with response to SPTLC2


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.12 0.02
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.084 0.02
mRNA PD-0332991 FIMM pan-cancer AAC 0.36 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.02
mRNA FH535 GDSC1000 pan-cancer AAC -0.081 0.03
mRNA compound 1B CTRPv2 pan-cancer AAC 0.088 0.03
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.03
mRNA decitabine CTRPv2 pan-cancer AAC 0.062 0.03
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.071 0.03
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.03
Download CSV